Use Cases

Discover how SciBite’s powerful solutions are supporting scientists and researchers.

Use Cases Overview

Gartner report

Gartner® How to Build Knowledge Graphs That Enable AI-Driven Enterprise Applications

 

Access report

Knowledge Hub

Explore expert insights, articles, and thought leadership on scientific data challenges.

Knowledge Hub

Resources

Discover our whitepapers, spec sheets, and webinars for in-depth product knowledge.

Resources

Events

Join us at upcoming events and webinars to learn more about SciBite solutions.

Events

News

Stay informed with the latest SciBite updates, announcements, and industry news.

News

About SciBite

Explore SciBite’s full suite of solutions to unlock the potential of your data.

Discover more about us

Our Partners

We build powerful partnerships with world-leading organizations.

Our Partners

Using knowledge graphs to drive epigenetic target discovery in oncology with AstraZeneca [Use Case]

While the impact of GenAI on pharma R&D is promising, it’s crucial to prioritize actual outcomes over hype. That’s why the relevant, quality dataset, with enriched metadata can help turn content into insights.

So, what constitutes the right data foundation? Pharmaceutical companies like yours face a daunting challenge in staying on top of the published literature, as well as ensuring it’s in a format that can be easily integrated with internal data sources. To ensure data quality and provenance, it’s crucial to access the most relevant information. But, how do you know you have the right data you need?

  • Collecting information based on journal title or subject collection alone?
  • You could miss relevant articles and insights – up to 2.5x more – dependent on the therapeutic area.

Learn how by working with Elsevier an Oncology team at AstraZeneca was able to assemble the literature base and build a powerful suite of computational tools to increase the efficiency and depth of target discovery in the epigenetic space, including an order of magnitude increase in the search space for new epigenetic targets.

Want to learn more about how AI and the right data can make a difference to pharma?

Share this article
Relevant resources, events and news